Free Trial

Versigent Q3 Earnings Call Highlights

Versigent logo with background
Image from MarketBeat Media, LLC.

Key Points

  • Q3 results improved despite weaker auto production: Sales rose 7% to $2.45 billion, adjusted EBITDA increased 11% to $275 million, and adjusted EPS climbed to $1.91. Net income and free cash flow declined year over year, partly reflecting higher interest expense.
  • Versigent raised its 2026 free cash flow outlook to $275 million–$325 million from $200 million–$300 million and narrowed its adjusted EBITDA forecast to $970 million–$1.01 billion, leaving the midpoint unchanged at $990 million.
  • The company booked $2.1 billion in new business in Q3, bringing year-to-date awards to $7.5 billion, while regional results diverged: adjusted sales rose 9% in Asia Pacific but fell 8% in EMEA.
  • MarketBeat previews the top five stocks to own by December 1st.

Versigent NYSE: VGNT raised its full-year free cash flow outlook and narrowed its earnings forecast after reporting higher third-quarter sales and adjusted earnings, even as global automotive production declined.

The company reported net sales of $2.45 billion for the third quarter of 2026, up 7% from a year earlier. Adjusted net sales, which exclude foreign exchange effects and commodity pass-throughs, rose approximately 1%, while global automotive production fell approximately 2%, Chief Financial Officer Doug Ostermann said.

Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) increased 11% to $275 million, and the adjusted EBITDA margin expanded 40 basis points to 11.2%. Adjusted diluted earnings per share rose to $1.91 from $1.81.

Net income attributable to Versigent declined to $102 million from $109 million, primarily because of higher interest expense associated with debt issued in the first quarter, partly offset by a lower income tax provision. Free cash flow slipped to $170 million from $179 million.

Cash Flow Forecast Rises

Versigent raised its 2026 free cash flow guidance to a range of $275 million to $325 million, from $200 million to $300 million. Ostermann attributed the increase to performance through the first nine months and the expected shift of certain initiatives into 2027.

The company maintained its expectation for approximately $1 billion in cumulative free cash flow from 2026 through 2028. Ostermann said some restructuring work planned for the fourth quarter had shifted to the first or second quarter of next year, partly because of discussions with customers about timing.

Versigent raised the low end of its annual sales outlook, projecting $9.5 billion to $9.6 billion, compared with $9.4 billion to $9.6 billion previously. Ostermann said the higher midpoint reflected updated copper assumptions and related customer pass-throughs, rather than an improvement in the underlying sales outlook. The company continues to expect adjusted net sales growth of approximately 2%.

Management narrowed its adjusted EBITDA forecast to $970 million to $1.01 billion from $950 million to $1.03 billion, keeping the midpoint at $990 million. Versigent now assumes an average 2026 copper price of approximately $6.25 per pound, up from $6 in its prior guidance.

Ostermann cautioned that the third-quarter adjusted EBITDA margin should not be treated as a new run rate. During the question-and-answer session, he said the full-year forecast implied a fourth-quarter margin of about 9.8%, while emphasizing that results can vary with launch costs, customer recoveries and other factors.

Launch Activity and Regional Results

Chief Executive Officer Joe Liotine said Versigent had launched more than 115 programs through September, with nearly half occurring in the third quarter. The programs served more than 35 customers across automotive and other markets. He said the company achieved greater than 99% quality and on-time delivery across those launches.

Versigent secured $2.1 billion in new business awards during the quarter, bringing year-to-date bookings to $7.5 billion. Liotine said bookings were on track with the company’s targets, although additional awards were expected before year-end.

In Asia Pacific, reported sales rose 18% and adjusted sales increased 9%, supported by global and local automakers. Ostermann said approximately 35% of Versigent product sales manufactured in China were ultimately installed on vehicles exported from the country.

Americas sales rose 6% to approximately $1.1 billion, with adjusted growth of 1%. Europe, the Middle East and Africa sales fell 6% to approximately $471 million, and adjusted sales declined 8%. Ostermann attributed the regional decline to weak consumer demand, softer vehicle production and program roll-offs. He also said some production serving European demand had shifted to China, affecting regional sales patterns.

Net pricing added approximately $21 million to third-quarter sales, primarily reflecting commercial recoveries related to certain prior-period electric vehicle program cancellations. Ostermann said the timing of such recoveries can vary as customer discussions take time to resolve.

Investment and Shareholder Returns

Liotine said the company is investing in new manufacturing facilities in Malaysia and India and expanding its engineering center in Pune, India. Versigent is also pursuing opportunities in markets including commercial vehicles, agriculture, battery energy storage, power generation and robotics.

One battery energy storage program is already in serial production, but Liotine described it as small and not material to revenue. He said robotics-related work included early development engagements and small production awards, while cautioning against extrapolating from those projects.

Versigent declared a quarterly dividend of $0.13 per ordinary share, payable December 17 to shareholders of record on December 4. Its $250 million share repurchase authorization remains available. Asked about buybacks, Ostermann said they remain an option within the company’s capital allocation framework.

Management plans to provide 2027 guidance on its next earnings call. Ostermann said separation costs, expected to be approximately $70 million to $75 million this year, should fall by about half next year, while interest expense is expected to rise because the company will have a full year of interest payments.

About Versigent (NYSE:VGNT)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Versigent Right Now?

Before you consider Versigent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.

While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines